ADVISORY | Metcela Inc.



    • President of Anioplex, LLC, a global strategy, business, and technical advisory firm serving startups, multinational corporations, venture capital firms and universities
    • Research expertise in regenerative medicine, stem cells, and gene therapy and biomaterials at Harvard Medical School, Kyoto University and UCLA
    • Ph.D in Biomedical Engineering from UCLA, J.D. from Santa Clara University with High Tech Law Certificate with corporate specialization and honors


    • Currently serves as a Chief Medical Officer at Medventure Partners, Inc.
    • Works as a research associate of cardiovascular medicine at Stanford University where he is responsible for preclinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases
    • Visiting Professor at T-CReDO (Tsukuba Clinical Research & Development Organization) since 2019


    • Directs the Cardiovascular Stem Cell Laboratory and Stanford Cardiothoracic MRI Program
    • Research interest focuses on translational effort of iPSC-derived small molecules for cardiovascular restoration
    • Received BAS and MA from Stanford University and M.D. from Yale University School of Medicine, and completed post-graduate training at UCLA and Stanford University Medical Centers